Juvenile pemphigus vulgaris: efficacy of moderate doses of deflazacort

Pediatr Dermatol. 1991 Sep;8(3):221-3. doi: 10.1111/j.1525-1470.1991.tb00864.x.

Abstract

A 13-year-old girl with pemphigus vulgaris (PV) had clinical features of chronic stomatitis. The histologic and immunologic findings were typical of a diagnosis of PV. Good therapeutic results were obtained with moderate doses of deflazacort, 1 mg/kg/day slowly tapered to 0.1 mg/kg every other day. The patient had no significant side effects.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use*
  • Drug Administration Schedule
  • Female
  • Humans
  • Pregnenediones / administration & dosage
  • Pregnenediones / therapeutic use*
  • Remission Induction

Substances

  • Anti-Inflammatory Agents
  • Pregnenediones
  • deflazacort